These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11105487)

  • 1. The ALERT MDT Field Evaluation Study (AMFES): a descriptive study of leprosy in Ethiopia. Patients, methods and baseline characteristics.
    Saunderson P; Gebre S; Desta K; Byass P
    Lepr Rev; 2000 Sep; 71(3):273-84. PubMed ID: 11105487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Field evaluation of WHO-MDT of fixed duration at ALERT, Ethiopia: the AMFES project--I. MDT course completion, case-holding and another score for disability grading.
    de Rijk AJ; Gabre S; Byass P; Berhanu T
    Lepr Rev; 1994 Dec; 65(4):305-19. PubMed ID: 7861917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pattern of leprosy-related neuropathy in the AMFES patients in Ethiopia: definitions, incidence, risk factors and outcome.
    Saunderson P; Gebre S; Desta K; Byass P; Lockwood DN
    Lepr Rev; 2000 Sep; 71(3):285-308. PubMed ID: 11105488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Field evaluation of WHO-MDT of fixed duration, at ALERT, Ethiopia: the AMFES project--II. Reaction and neuritis during and after MDT in PB and MB leprosy patients.
    de Rijk AJ; Gabre S; Byass P; Berhanu T
    Lepr Rev; 1994 Dec; 65(4):320-32. PubMed ID: 7861918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nerve function impairment in leprosy at diagnosis and at completion of MDT: a retrospective cohort study of 786 patients in Bangladesh.
    Richardus JH; Finlay KM; Croft RP; Smith WC
    Lepr Rev; 1996 Dec; 67(4):297-305. PubMed ID: 9033200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relapses among leprosy patients treated with multidrug therapy: experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia; practical difficulties with diagnosing relapses; operational procedures and criteria for diagnosing relapses.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):421-35. PubMed ID: 1474281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with impairments in new leprosy patients: the AMFES cohort.
    Meima A; Saunderson PR; Gebre S; Desta K; van Oortmarssen GJ; Habbema JD
    Lepr Rev; 1999 Jun; 70(2):189-203. PubMed ID: 10464437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses after fixed duration multiple drug therapy: the AMFES cohort.
    Gebre S; Saunderson P; Byass P
    Lepr Rev; 2000 Sep; 71(3):325-31. PubMed ID: 11105491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
    Penna GO; Bührer-Sékula S; Kerr LRS; Stefani MMA; Rodrigues LC; de Araújo MG; Ramos AMC; de Andrade ARC; Costa MB; Rosa PS; Gonçalves HS; Cruz R; Barreto ML; Pontes MAA; Penna MLF
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005725. PubMed ID: 28704363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological shift in leprosy in a rural district of central India following introduction of multi-drug therapy (April 1986 to March 1992 and April 1992 to March 2002).
    Pandey A; Uddin MJ; Patel R
    Lepr Rev; 2005 Jun; 76(2):112-8. PubMed ID: 16038244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR; De Alencar Mde J; De Sena Neto SA; Lehman LF; Schreuder PA
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology of reactions and nerve damage.
    Saunderson P
    Lepr Rev; 2000 Dec; 71 Suppl():S106-10. PubMed ID: 11201864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse and deformity among 2177 leprosy patients released from treatment with MDT between 2005 and 2010 in South India: A retrospective cohort study.
    Prabu R; Manickam P; Mahalingam VN; Jayasree P; Selvaraj V; Mehendale SM
    Lepr Rev; 2015 Dec; 86(4):345-55. PubMed ID: 26964430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with WHO-recommended multidrug therapy (MDT) for multibacillary (MB) leprosy patients in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center in Ethiopia: appraisal of the recommended duration of MDT for MB patients.
    Becx-Bleumink M
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):558-68. PubMed ID: 1802938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal reactions in the skin lesions of AMFES patients: incidence and risk factors.
    Saunderson P; Gebre S; Byass P
    Lepr Rev; 2000 Sep; 71(3):309-17. PubMed ID: 11105489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV; Balagon MF; dela Cruz EC; Burgos JA; Abalos RM; Walsh GP; Topolski R; Gelber RH; Walsh DS
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial to compare cure and relapse rate of paucibacillary multidrug therapy with monthly rifampicin, ofloxacin, and minocycline among paucibacillary leprosy patients in Agra District, India.
    Kumar A; Girdhar A; Girdhar BK
    Indian J Dermatol Venereol Leprol; 2015; 81(4):356-62. PubMed ID: 26144850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K; Schreuder PA; Pirayavaraporn C
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.